What Is Type 3 Diabetes? Insulin Resistance In The Brain That Could Trigger Alzheimer’s
Most people are aware of type 1 and type 2 diabetes, but did you know there is a type 3 diabetes as well! It is a more obscure term. Although it is not an accepted medical diagnosis, type 3 diabetes has been discussed in the literature as a possible relationship between insulin resistance in the brain and Alzheimer's disease. This link has been described to help explain how metabolic disorders impact brain health, causing cognitive decline and dementia.
Type 3 diabetes is more of a misnomer because it should not be confused with type 3c diabetes, which relates to pancreatic dysfunction. The term "type 3 diabetes," on the other hand, has been loosely used by some scientists to analogously propose that Alzheimer's disease is strongly implicated with insulin resistance in the brain.
This concept was conceptualized by Dr. Suzanne de la Monte and Dr. Jack Wands of Brown University in the year 2008. This hypothesis postulated that Alzheimer's disease may be called type 3 diabetes for it bears many similarities with glucose metabolism disorder type 2 diabetes. Their concept arises from the basic principle that insulin is fundamental to blood sugar regulation, but it is also the case with the brain. When brain cells become insulin-resistant, they lose access to glucose, impairing their function.
Research published in the Journal of Diabetes Science and Technology supports this hypothesis by indicating that insulin resistance can be a significant contributor to the occurrence of dementia, also referred to as Alzheimer's. The symptoms of memory loss and diminished reasoning are associated with impaired glucose metabolism in the body, especially in the cerebral tissue.
Although type 3 diabetes is not a "medical term," its symptoms correlate well with Alzheimer's diseases that are known to reduce the ability to think in an efficient manner and bring down brain health. These signs are:
- Loss of memory, especially short-term.
- Poor judgment and judgment ability
- Failure in recognizing people or places familiar once.
- Failure in the process of reading, writing or processing numbers
- Anxiety, agitation, or mood changes.
- Disorganized thoughts or confusion
- Lack of impulse control
As the disease advances, patients may be afflicted with severe complications including an inability to swallow or control their bodily functions. In the final stages, most patients die from fatal complications such as aspiration pneumonia.
This may not be well understood with regards to type 3 diabetes, or the exact link between insulin resistance and Alzheimer's disease. Some identified contributing factors include the following:
Insulin acts as an important regulatory mechanism of brain functions such as memory and cognition. The reduction in insulin signaling may impair metabolism of brain cells, thus bringing about neurodegeneration.
These diseases show a strong relationship and those individuals diagnosed with type 2 diabetes have double chances of getting Alzheimer's. In the two, the main causes can be chronic inflammation, oxidative stress, and a defect in glucose metabolism.
Insulin resistance associated with obesity, stress, and an unhealthy diet is considered a cause that may increase the chances of Alzheimer's disease.
Researches in Frontiers in Neuroscience and The Lancet Neurology have also highlighted that drugs used for antidiabetic medication may be crucial for the prevention or at least slowing down the course of Alzheimer's.
In 2022, in a study in Pharmaceuticals, researchers studied biomarker uptake in brain regions implicated in the faulty uptake and metabolism of blood sugar in Alzheimer’s patients.
Emerging Therapies
Research into such treatments as intranasal insulin has also been promising. Intranasal delivery of insulin directly to the brain has been reported to enhance glucose uptake by brain cells, improve memory, and boost cognitive performance. While such clinical trials have been shown to be successful, additional research is needed for safety and efficacy.
Medications
For patients being aggressive or agitated, antipsychotic drugs may be prescribed; however, therapies such as cognitive rehabilitation as well as cognitive stimulation therapy serve to preserve memory and executive function.
Lifestyle Interventions
Diet, exercise, and stress management are critical in preventing and managing insulin resistance. A review in the Journal of Alzheimer's Disease also highlighted the benefits of Kirtan Kriya meditation, which can regulate genes involved in insulin and glucose metabolism, improve sleep, and reduce inflammation.
Although type 3 diabetes is not officially recognized, its connection to Alzheimer’s disease underscores the importance of proactive measures for brain health. Some prevention strategies include:
1. Healthy Diet
Consuming a balanced diet rich in antioxidants, whole grains, and healthy fats may support brain health.
2. Regular Exercise
Physical activity improves insulin sensitivity, reduces inflammation, and enhances overall metabolic health.
3. Stress Reduction
Mindfulness practices, including meditation, have been shown to lower stress levels, which can reduce the risk of cognitive decline.
The term type 3 diabetes brings out the complex relationship between metabolic disorders and brain health. Even though it is not a recognized medical condition, the concept emphasizes the crucial role of insulin in brain function and its possible contribution to Alzheimer's disease. Continued research will hopefully provide hope for therapies such as intranasal insulin and lifestyle modifications.
Credit: AI
Doctors have reached a major milestone in minimally invasive lung care. They have removed a suspected endobronchial carcinoid tumor from a patient's airway without needing to perform open chest surgery. The procedure combined four advanced bronchoscopic techniques to successfully remove the tumour while saving the patient’s lung tissue.
A 40 year old male patient from Gurugram came in with breathlessness. Additional examinations revealed partially obstructing the airway and interfering with the patient’s normal breathing. Because of where the tumour was and what it looked like, doctors decided to do the advanced bronchoscopic procedure rather than a more invasive surgery.
Also read: Is It Just A Persistent Cough Or Is Your Body Telling You Something Else?
Endobronchial carcinoid tumours are slow growing but highly vascular and can bleed profusely when excised. Precise instrumentation, careful planning and efficient control of bleeding are required to treat them within the narrow air passage. To overcome these challenges the team employed a multimodality approach that included flexible fibreoptic bronchoscopy to access and visualise the tumour, electrocautery to cut and debulk the growth, Argon Plasma Coagulation (APC) to seal blood vessels and control bleeding and cryotherapy to freeze and extract tumour tissue and treat the residual base.
The combined approach allowed the team to completely remove the tumour and restore airway patency with no need for an external incision. The patient [recovered well and was discharged within X days/is recovering well], while the excised tissue has been sent for histopathological examination to confirm the diagnosis.
Endobronchial tumours such as carcinoids can bleed heavily, so every step has to be planned in advance. By combining electrocautery, argon plasma coagulation and cryotherapy through a flexible bronchoscope, we were able to remove the tumour completely while keeping bleeding under control. For carefully selected patients, this approach can avoid open surgery and the loss of healthy lung tissue.
Traditionally, some endobronchial tumours have required surgical removal of the affected portion of the lung. Advances in interventional pulmonology are expanding treatment possibilities, allowing appropriately selected patients to undergo tumour removal through the natural airway. This approach can help avoid external incisions as well as reduce post procedure pain, shorten hospital stays and support faster recovery.
This achievement shows just how important advanced therapeutic bronchoscopy has become for treating complex airway conditions.
Credit: AI
Lung cancer is usually linked to smoking yet there is more to the tale behind who gets the disease in India. More men suffer from lung cancer than women. This does not happen by coincidence because of the differences in the number of smokers.
According to the Global Cancer Observatory (GLOBOCAN 2022), lung cancer is one of the most common cancers among Indian males. There is a substantial difference in the prevalence rate of cancer between men and women, and the former group bears a higher burden of the disease. One needs to go deeper into the problem to find an explanation.
Tobacco consumption is one of the most important factors influencing the likelihood of suffering from cancer. Traditionally, smoking was a practice more common among men in India. According to the results of the Global Adult Tobacco Survey (GATS-2, 2016-17), about 24 per cent of Indian men had ever consumed tobacco, compared to just 14 per cent of women.
Cigarette smoke and bidis contain harmful chemicals that cause gradual damage to the tissues lining the airways. Such repeated exposure makes changes in genes more probable, which ultimately results in the occurrence of cancer. Moreover, the risk becomes higher depending on the length and severity of smoking.
Gender differences in the workforce in India may contribute to additional exposure to cancer-causing substances as well. Male employees in such occupations as construction, mining, manufacturing, transportation and some industries may be exposed to asbestos, silica dust, diesel engine exhausts and other hazardous agents. As a result, they become at greater risk of developing lung cancer due to long-term exposure.
Air pollution may contribute to an increase in the risk of lung cancer as well. Inhalation of fine particulates, especially PM2.5, is able to penetrate deeply into the lungs and cause cancer. According to IARC, outdoor air pollution and particulate matter are carcinogenic to humans.
Nevertheless, women may suffer from environmental risk factors too. Inhalation of smoke caused by solid fuel combustion in kitchens with poor ventilation and passive exposure to cigarette smoke pose additional risks for female patients.
Also read: Lung Cancer Survival Improves By 71% In US: But 1 In 5 Patients Still Gets No Treatment
One common myth is that lung cancer only affects smokers. Some women develop lung cancer without any history of smoking. Some lung cancers, especially some kinds of adenocarcinomas, occur in people with no past of smoking. These cancers could have unique features and genetic mutations that could assist in identifying targeted therapy for this condition.
This is why an individual assessment of each case of lung cancer is necessary rather than jumping to conclusions about what caused the cancer based on whether one smokes or not.
While men might disregard cough, shortness of breath, or chest pains as being results of smoking, pollution, or age, women might struggle with the same problem due to the fact that they do not smoke.
A persistent cough for weeks, bloody sputum, unintentional weight loss, constant chest pain, or an increasing level of breathlessness is never to be dismissed. Symptoms like these do not always mean cancer, yet they need a proper medical evaluation.
Gender differences in the incidence of lung cancer depend on behavioral, environmental, occupational, and biological factors. It is essential to stop smoking, create safe workplaces, reduce pollution of the air, and have an early diagnosis for both men and women.
Lung cancer cannot be viewed as a man's disease or the outcome of smoking. The chances might differ, but it needs to be universally recognized and treated.
Credit: iStock
Even if diabetes is kept under control kidney function can still get worse over time. Good control of blood sugar cuts the risk of kidney disease a lot but it does not remove the risk entirely.
The risk depends on things, such as how long one has had diabetes years of poor blood sugar control, high blood pressure being overweight genes and heart disease. Sometimes kidney damage that started when blood sugar was high before can keep showing up after blood sugar improves later.
One key point is that HbA1c by itself does not show kidney health. A person may have a HbA1c of 6.5 percent yet still have early kidney damage with no signs. That is why regular kidney screening is vital.
I recommend two tests for every person with diabetes: urine albumin-to-creatinine ratio, called UACR and estimated glomerular filtration rate, called eGFR. These tests reveal kidney damage early before any symptoms. People with type 2 diabetes should have these tests at once a year.
In addition to blood sugar control keeping blood pressure low staying at a healthy weight exercising often avoiding needless painkillers and quitting smoking are key ways to protect kidneys. New medicines, SGLT2 inhibitors and for some people, finerenone have shown strong kidney protection
Controlling blood sugar matters. Protecting kidneys needs more than just diabetes control. Regular screening and early treatment can greatly lower the chance of kidney disease and the need, for dialysis.
By Dr. Ronak Bhalodia, Dr NB Nephrology, MD Medicine, Sterling Hospital, Rajkot
© $2026 Times Horizon Private Limited